Watching the presentation from Dr Seethamraju around the 4 minute mark he says the dsmb and FDA are reviewing the unblinded data. I thought the dsmb reviews and makes a recommendation. Was that just a misspeak or a misunderstanding on my part of how the interim analysis works?